Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02763150 · ClinicalTrials.gov registry record · NA

Pre-pregnancy Lifestyle Intervention to Prevent the Recurrence of Gestational Diabetes in Overweight and Obese Women

A NA study of Gestational Diabetes Mellitus, sponsored by California Polytechnic State University-San Luis Obispo.

Completed
Registry status
NA
Development phase
199
Enrollment target
2
Study locations

NCT02763150 is a NA study of Gestational Diabetes Mellitus that has completed, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 199 participants, below the 407-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02763150, a NA study of Gestational Diabetes Mellitus, has completed, sponsored by California Polytechnic State University-San Luis Obispo.

COMPLETED
Registry status
NA
Development phase
199 participants
Enrollment target
2
Study locations

Study Summary

The overall purpose of this study is to determine the efficacy of a pre-pregnancy lifestyle intervention to reduce the recurrence of gestational diabetes mellitus in multiethnic women with overweight or obesity.

Interventions

  • OTHER Health Promotion
  • BEHAVIORAL Lifestyle intervention

Study Locations (2)

California

  • California Polytechnic State University - San Luis Obispo

Rhode Island

  • Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 199 participants
Start Date 2017-12-15
Est. Completion 2022-07-29
Phase NA

What the Registry Record Tells You About NCT02763150

The ClinicalTrials.gov registry entry for NCT02763150 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 407-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (51% lower). The listed sponsor is California Polytechnic State University-San Luis Obispo, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gestational Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Health Promotion is the first listed.

NCT02763150 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT02763150 about?

NCT02763150 is a clinical study titled "Pre-pregnancy Lifestyle Intervention to Prevent the Recurrence of Gestational Diabetes in Overweight and Obese Women". The overall purpose of this study is to determine the efficacy of a pre-pregnancy lifestyle intervention to reduce the recurrence of gestational diabetes mellitus in multiethnic women with overweight or obesity.

What is the current status of trial NCT02763150?

This trial is currently completed. It is a NA study. The enrollment target is 199 participants. The study started on 2017-12-15. Estimated completion is 2022-07-29.

What conditions does trial NCT02763150 study?

This clinical trial studies the following conditions: Gestational Diabetes Mellitus.

What interventions are being tested in trial NCT02763150?

The interventions under investigation include: Health Promotion (OTHER), Lifestyle intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02763150?

This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02763150 being conducted?

This trial has 2 study locations across California, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.